ATE121788T1 - Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse. - Google Patents

Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse.

Info

Publication number
ATE121788T1
ATE121788T1 AT90902656T AT90902656T ATE121788T1 AT E121788 T1 ATE121788 T1 AT E121788T1 AT 90902656 T AT90902656 T AT 90902656T AT 90902656 T AT90902656 T AT 90902656T AT E121788 T1 ATE121788 T1 AT E121788T1
Authority
AT
Austria
Prior art keywords
factor beta
monoclonal antibodies
blood clotting
clotting factor
immune analysis
Prior art date
Application number
AT90902656T
Other languages
English (en)
Inventor
Michael Peter Esnouf
Original Assignee
Coagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coagen Ltd filed Critical Coagen Ltd
Application granted granted Critical
Publication of ATE121788T1 publication Critical patent/ATE121788T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90902656T 1989-01-27 1990-01-29 Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse. ATE121788T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898901859A GB8901859D0 (en) 1989-01-27 1989-01-27 Diagnostic test

Publications (1)

Publication Number Publication Date
ATE121788T1 true ATE121788T1 (de) 1995-05-15

Family

ID=10650741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90902656T ATE121788T1 (de) 1989-01-27 1990-01-29 Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse.

Country Status (12)

Country Link
EP (1) EP0455707B1 (de)
JP (1) JP2916252B2 (de)
AT (1) ATE121788T1 (de)
AU (1) AU641912B2 (de)
CA (1) CA2045475C (de)
DE (1) DE69018968T2 (de)
DK (1) DK0455707T3 (de)
ES (1) ES2072423T3 (de)
GB (1) GB8901859D0 (de)
IL (1) IL93207A (de)
NZ (1) NZ232273A (de)
WO (1) WO1990008835A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963657A (en) * 1988-06-09 1990-10-16 Temple University Of The Commonwealth System Of Higher Education Monoclonal antibodies to the light chain region of human factor XII and methods of preparing and using the same
CA2082643A1 (en) * 1990-05-10 1991-11-11 Jan H. Nuijens Inhibitors of factor xii activation and applications thereof
EP0759556A3 (de) * 1995-07-24 1998-05-20 BEHRINGWERKE Aktiengesellschaft Verfahren zur Quantifizierung aktivierter Faktoren
WO2004057343A2 (en) * 2002-12-20 2004-07-08 Axis-Shield Diagnostics Limited Detection or determination of variants of factor xiia
GB0500487D0 (en) * 2005-01-11 2005-02-16 Axis Shield Diagnostics Ltd Forms of factor XIIa
GB0607515D0 (en) * 2006-04-13 2006-05-24 Axis Shield Diagnostics Ltd Anti-factor xlla therapy
EP2548892A1 (de) 2011-07-22 2013-01-23 CSL Behring GmbH Inhibitorische Antikörper gegen Factor XII/XIIa und ihre Verwendungen
IL230564B2 (en) 2011-07-22 2023-09-01 Csl Ltd Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses.
EP2623110A1 (de) 2012-01-31 2013-08-07 CSL Behring GmbH Faktor-XII-Hemmer zur Behandlung neurologischer Entzündungserkrankungen
CN105188750A (zh) 2013-03-08 2015-12-23 德国杰特贝林生物制品有限公司 治疗和预防远端缺血-再灌注损伤
CA2916399C (en) 2013-06-28 2022-08-02 Marc Nolte Combination therapy using a factor xii inhibitor and a c1-inhibitor
JP7109160B2 (ja) 2014-06-18 2022-07-29 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 神経外傷性障害において第ｘｉｉ因子インヒビターを使用する療法
CN107405399B (zh) 2015-01-02 2022-02-08 武田药品工业株式会社 针对血浆激肽释放酶和因子xii的双特异性抗体
AU2016297018B9 (en) * 2015-07-21 2022-12-01 Takeda Pharmaceutical Company Limited A monoclonal antibody inhibitor of factor XIIa

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963657A (en) * 1988-06-09 1990-10-16 Temple University Of The Commonwealth System Of Higher Education Monoclonal antibodies to the light chain region of human factor XII and methods of preparing and using the same

Also Published As

Publication number Publication date
EP0455707B1 (de) 1995-04-26
EP0455707A1 (de) 1991-11-13
WO1990008835A1 (en) 1990-08-09
CA2045475C (en) 2000-04-04
ES2072423T3 (es) 1995-07-16
IL93207A (en) 1994-02-27
GB8901859D0 (en) 1989-03-15
JPH04503006A (ja) 1992-06-04
CA2045475A1 (en) 1990-07-28
DE69018968T2 (de) 1995-08-24
AU5030590A (en) 1990-08-24
NZ232273A (en) 1992-03-26
AU641912B2 (en) 1993-10-07
JP2916252B2 (ja) 1999-07-05
DK0455707T3 (da) 1995-06-26
DE69018968D1 (de) 1995-06-01
IL93207A0 (en) 1990-11-05

Similar Documents

Publication Publication Date Title
ES548270A0 (es) Un metodo de inmunoensayo
ATE121788T1 (de) Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse.
ATE245169T1 (de) Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
DE69200460D1 (de) Agglutinationskomplex zum Nachweis von Blutgruppen.
DE69529106D1 (de) Monoklonaler Antikörper gegen denThrombin-Antithrombin III-Komplex und dessen Verwendung in Immunoassays
DK484588A (da) Monoklonalt antistof, der genkender a-hanp, og reagens til immunoanalyse af a-hanp
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
FI882019L (fi) Monoklonaalisia vasta-aineita intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) selektiivistä, immunologista määritystä varten kehonnesteistä
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
DE3852914D1 (de) Monoklonale Antikörper und Diagnoseverfahren für Phytophthora-Infektionen.
ES2029890T3 (es) Inmunoensayo.
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee